Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.51 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.51 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20104346 | 0.97 | NUDT1 (0.46) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL31683834 | 0.81 | LIPG (0.61) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL17412374 | 0.81 | LIPG (0.61) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL19106655 | 0.81 | LIPG (0.61) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL19106647 | 0.81 | LIPG (0.61) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL23352767 | 0.81 | LIPG (0.61) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL28523446 | 0.80 | ALDH1A1 (0.46) | NUDT1ADORA2AALDH1A1MEN1KMT2A | |
| SCHEMBL31644060 | 0.80 | LIPG (0.59) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL19106654 | 0.80 | LIPG (0.59) | LPLLIPGNUDT1ADORA2AALDH1A1 | |
| SCHEMBL17412355 | 0.80 | LIPG (0.59) | LPLLIPGNUDT1ADORA2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415949-B2 | Compound, organic electroluminescent device, and display device | SK INC. (KR) | 2025-09-16 | — | — | US | disclosed |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| CN-112262144-A | Compound, organic electroluminescent device and display device | SK材料有限公司 | 2021-01-22 | — | — | CN | disclosed |
| US-20200048207-A1 | COMPOUNDS WITH ARYLAMINE STRUCTURES | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415949-B2 | Compound, organic electroluminescent device, and display device | L1CAM, EML4, OCIAD2 | LPL 159/4885LIPG 266/4885NUDT1 603/4885 |
| US-20200048207-A1 | COMPOUNDS WITH ARYLAMINE STRUCTURES | DDT, NAT1, INMT | LPL 4565/4885LIPG 3273/4885NUDT1 15/4885 |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | L1CAM, EML4, OCIAD2 | LPL 159/4885LIPG 266/4885NUDT1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.